stockrow
Friday 6 November 2026
Export CERS’s income statement to Excel — free account
Cerus Corporation
CERS Healthcare Medical Devices
- Revenue
- +6.28%
- EPS
- −2,800.0%
- Free cash flow
- +2,471.3%
- Total debt
- −25.4%
Quarter to September 2026, against a year earlier
2.03
0.10
−4.69%
Follow CERS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 5 | 5 |
+8 more TTM periods Free account |
| (10.56%) | (10.69%) | (15.34%) | (25.65%) | ||
| (3.48%) | (3.24%) | (4.45%) | (7.39%) | ||
ROIC |
(1.87%) | (1.27%) | (2.74%) | (8.22%) | |
Return on Tangible Assets |
(8.51%) | (8.38%) | (12.37%) | (18.88%) | |
Average Days of Receivables |
44.30 | 45.59 | 43.71 | 47.42 | |
Free Cash Flow per Share |
0.00 | (0.01) | (0.01) | 0.01 | |
Free Cash Flow |
0.49 | (1.83) | (1.22) | 1.11 | |
Capital Expenditures |
(3.00) | (4.25) | (3.85) | (3.73) | |
| Other line items | |||||
Cash ROIC |
0.25% | (0.95%) | (0.52%) | 0.48% | |
Accounts Receivable Turnover |
8.35 | 7.95 | 8.80 | 7.77 | |
Accounts Payable Turnover |
4.27 | 3.32 | 3.42 | 3.78 | |
Inventory Turnover |
1.85 | 1.77 | 1.86 | 1.99 | |
Average Days of Payables |
85.84 | 115.16 | 113.98 | 108.93 | |
Days of Inventory on Hand |
216.37 | 226.12 | 219.16 | 218.20 | |
Tax Rate |
0.05 | 0.06 | 0.04 | 0.02 | |
Research and Development Expense of Revenue |
23.66% | 24.65% | 26.81% | 28.97% | |
Selling, General and Administrative Expense of Revenue |
33.98% | 33.17% | 32.91% | 34.61% | |
Share Based Compensation of Revenue |
8.51% | 8.45% | 8.63% | 9.78% | |
Interest Coverage |
(0.36) | (0.21) | (0.39) | (1.04) | |
Operating CF/Net income |
(0.48) | (0.36) | (0.28) | (0.31) | |
Depreciation/Fixed assets |
0.18 | 0.18 | 0.17 | 0.15 | |
Capex/Depreciation |
(1.74) | (2.52) | (2.46) | (2.61) | |
Revenue per Share |
1.25 | 1.24 | 1.26 | 1.23 | |
Operating CF per Share |
0.02 | 0.01 | 0.01 | 0.03 | |
Capex per Share |
(0.01) | (0.02) | (0.02) | (0.02) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026